SCHEMBL7688725

SCHEMBL7688725

CC(N(C)C)n1cnc2nc[nH]c2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ PDPK1 O15530 2/20 0.38
▸ CHEK1 O14757 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ MARK3 P27448 1/20 0.38
▸ RPS6KA3 P51812 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ MARK2 Q7KZI7 1/20 0.38
▸ ADORA2B P29275 6/20 0.36
▸ ADORA2A P29274 5/20 0.35
▸ ATAD2 Q6PL18 1/20 0.34
▸ PDE4A P27815 3/20 0.34
▸ PDE4B Q07343 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26248640 0.84 ALDH1A1 (0.47) ALDH1A1PDPK1CHEK1AURKACHEK2
SCHEMBL2115743 0.72 ALDH1A1 (0.52) ALDH1A1ADORA2BADORA2AATAD2PDE4A
SCHEMBL7688731 0.70 MEN1 (0.48) ALDH1A1MEN1KMT2A
SCHEMBL8354950 0.68 ALDH1A1 (0.52) ALDH1A1PDPK1CHEK1AURKACHEK2
SCHEMBL94914 0.68 ALDH1A1 (0.52) ALDH1A1PDPK1CHEK1AURKACHEK2
SCHEMBL18560720 0.68 ALDH1A1 (0.52) ALDH1A1PDPK1LRRK2ADORA2BADORA2A
SCHEMBL16513159 0.68 ALDH1A1 (0.52) ALDH1A1PDPK1CHEK1AURKACHEK2
SCHEMBL612165 0.68 ALDH1A1 (0.52) ALDH1A1PDPK1CHEK1AURKACHEK2
SCHEMBL26248657 0.68 ALDH1A1 (0.47) ALDH1A1ADORA2BADORA2APDE4APDE4B
SCHEMBL1866522 0.66 PDE4A (0.49) ALDH1A1ADORA2BADORA2APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085904-A1 SNYTHESIS AND METHODS OF USE OF PURINE ANALOGUES AND DERIVATIVES NEOTHERAPEUTICS, INC. (US) 2002-10-31 — — WO disclosed
US-20020156277-A1 Synthesis and methods of use of purine analogues and derivatives NEO THERAPEUTICS, INC. 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156277-A1 Synthesis and methods of use of purine analogues and derivatives SLC29A1, ATIC, PNP ALDH1A1 834/4885PDPK1 1997/4885CHEK1 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback